Robert W. Baird turned bullish on Humana Inc (HUM), upgrading the stock to Outperform and assigning a $596 price target, representing potential upside of 38.00% from Friday's close.
Fastly Inc (FSLY) has won the favor of Oppenheimer's equity research team. The firm upgraded the shares from Perform to Outperform and moved its price target to $35, suggesting 19.45% additional upside for the stock.
Houlihan Lokey Inc (HLI) received an upgrade from analysts at Citizens, who also set their one-year price target on the stock to $175. They changed their rating on HLI to Mkt Outperform from Mkt Perform in a recently issued research note.
Barclays reduced its rating on South Bow Corp (SOBO) stock to Underweight from Equal Weight and assigned the price target to $33.
Keefe Bruyette analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Genworth Financial Inc (GNW) has been changed to Mkt Perform from Outperform and the new price target is set at $11.
Analysts at JP Morgan downgraded DuPont de Nemours Inc (DD) stock to Neutral from Overweight, and the new price target is set at $145.